CASC
BLUE

Coppell Advisory Solutions Corp’s bluebird bio BLUE Stock Holding History

Coppell Advisory Solutions Corp’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-34
Closed -$9.51K – 295
2022
Q4 		$9.51K Buy
+34
New +$4.79K ﹤0.01% 622

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Coppell Advisory Solutions Corp's BLUE Position: Q1 2023 in Review

Coppell Advisory Solutions Corp sold out of bluebird bio (BLUE) in Q1 2023, closing a stake of 34 shares — an estimated $9.51K sold.

Coppell Advisory Solutions Corp first reported a position in BLUE in Q4 2022 and held it in 1 quarter. The position peaked at $9.51K in Q4 2022. 177 funds tracked by Wall St. Rank hold BLUE as of Q1 2023.

  • Coppell Advisory Solutions Corp reported no remaining bluebird bio position as of Q1 2023 after selling out during the quarter.
  • Coppell Advisory Solutions Corp sold 34 bluebird bio shares in Q1 2023, an estimated $9.51K.
  • Coppell Advisory Solutions Corp first reported a position in bluebird bio in Q4 2022 and held it in 1 quarter.
  • Coppell Advisory Solutions Corp's bluebird bio position peaked at $9.51K in Q4 2022.
  • 177 funds tracked by Wall St. Rank held bluebird bio as of Q1 2023.

Based on Coppell Advisory Solutions Corp's 13F filing for Q1 2023, filed 10 May 2023.